TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.20$ -0.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Upstream Bio, Inc. (UPB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 281 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UPB
Line item Q1 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – 117 – 245 233 482 456 421 391 354 318 281
– – 117 – 243 227 479 454 418 389 352 316 280
17 – 26 110 47 33 326 71 45 72 102 97 79
17 – 110 110 236 221 470 431 394 372 342 295 261
– – 0.2 – 0.9 1.1 1.2 1.7 2.6 0.7 0.7 1.0 2.2
-6.7 – 240 -108 391 393 12 11 12 13 14 14 10
– – 6.5 – 10 11 11 9.6 11 12 13 14 10.0
– – 0.0 – – 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7
– – 2.0 – 5.6 4.9 4.0 4.7 2.6 4.0 2.7 1.7 2.3
6.7 – -123 108 -147 -160 470 446 409 379 340 304 271
– – -128 – -154 -170 -191 -218 -258 -292 -334 -375 -415
– 36 36 51 51 51 51 54 54 54 54 54 55

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?